Delhi High Court has granted an injunction restraining the domestic pharma companies such as Cipla, Torrent, Emcure, Alkem from selling a medicine used for prevention and treatment of thromboembolic diseases, the patent for which is held by Bristol-Myers Squibb (BMS) as it filed its claims for patent infringement of Apixaban in Delhi HC.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2tPEqqr
via IFTTT
0 comments:
Post a Comment